Suppr超能文献

“O”血型镰状细胞病患者血管闭塞性危象增加:与潜在的血小板反应蛋白水平的关联。

Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

作者信息

Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho C H, Krishnamoorthy R, Pathare A V

机构信息

Sultan Qaboos University Hospital, Muscat, OMAN.

Sultan Qaboos University, College of Medicine and Health Sciences, Muscat, OMAN.

出版信息

Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017.

Abstract

OBJECTIVES

To explore the incidence of vaso-occlusive crisis (VOC) in Blood Group "O" sickle cell disease (SCD) patients, and correlate it with the blood group and thrombospondin (TSP) levels.

METHODS

In 89 consecutive SCD patients, blood samples were obtained for von Williebrand factor (vWF:Ag) antigen, collagen binding activity (CBA), ristocetin binding activity (RCo), blood group typing, C-reactive protein (CRP), high performance liquid chromatography (HPLC), Serum TSP 1 and TSP 2 levels, complete blood counts (CBC), lactic dehydrogenase (LDH) levels, liver function (LFT) and renal function tests (RFT) during VOC episodes and in steady state conditions.

RESULTS

In steady state SCD patients (n=72), "O" blood group patients (n=37) showed a significantly higher median serum TSP 1 and TSP 2 levels as compared to non-O blood group patients [n=35] [p <0.05, Mann-Whitney test]; with an inverse relation between vWF:Ag, Factor VIII:C and TSP levels. Furthermore, the serum TSP 1 and TSP 2 levels were significantly higher in patients presenting with acute VOC [n=17], as well as in those with repeated VOC's (group 1, n=16), especially amongst blood group "O" patients [p, <0.05, Mann-Whitney test].

CONCLUSIONS

The study demonstrates an inverse relation between TSP and vWF levels, in blood group "O" SCD patients, with an upregulation of the TSP levels. Expectedly, during active VOC crisis, the TSP 1 and TSP 2 levels were significantly elevated.

摘要

目的

探讨血型为“O”的镰状细胞病(SCD)患者血管闭塞性危机(VOC)的发生率,并将其与血型和血小板反应蛋白(TSP)水平相关联。

方法

在89例连续的SCD患者中,采集血样检测血管性血友病因子(vWF:Ag)抗原、胶原结合活性(CBA)、瑞斯托霉素结合活性(RCo)、血型分型、C反应蛋白(CRP)、高效液相色谱法(HPLC)、血清TSP 1和TSP 2水平、全血细胞计数(CBC)、乳酸脱氢酶(LDH)水平、肝功能(LFT)和肾功能测试(RFT),检测时间为VOC发作期间和病情稳定状态。

结果

在病情稳定的SCD患者(n = 72)中,血型为“O”的患者(n = 37)血清TSP 1和TSP 2的中位数水平显著高于非“O”血型患者[n = 35] [p <0.05,曼-惠特尼检验];vWF:Ag、凝血因子VIII:C与TSP水平呈负相关。此外,急性VOC患者(n = 17)以及反复发生VOC的患者(第1组,n = 16)血清TSP 1和TSP 2水平显著更高,尤其是在血型为“O”的患者中[p <0.05,曼-惠特尼检验]。

结论

该研究表明,在血型为“O”的SCD患者中,TSP与vWF水平呈负相关,且TSP水平上调。不出所料,在活跃的VOC危机期间,TSP 1和TSP 2水平显著升高。

相似文献

1
Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.
Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017.
2
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
Res Pract Thromb Haemost. 2020 Dec 18;5(1):197-203. doi: 10.1002/rth2.12460. eCollection 2021 Jan.
3
Thrombospondin-1 and Vitamin D in Children With Sickle Cell Anemia.
J Pediatr Hematol Oncol. 2019 Nov;41(8):e525-e529. doi: 10.1097/MPH.0000000000001368.
4
Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.
6
Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Hematology. 2014 Jan;19(1):52-9. doi: 10.1179/1607845413Y.0000000092. Epub 2013 Nov 25.
7
Determination of von Willebrand factor level in patient with sickle cell diseasein vaso-occlusive crisis.
Res Pract Thromb Haemost. 2020 Jul 10;4(5):902-905. doi: 10.1002/rth2.12378. eCollection 2020 Jul.
9
Clinical significance of assessment of thrombospondin and placenta growth factor levels in patients with sickle cell anemia: two centers egyptian studies.
Mediterr J Hematol Infect Dis. 2014 Jul 1;6(1):e2014044. doi: 10.4084/MJHID.2014.044. eCollection 2014.
10

本文引用的文献

1
Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.
JCI Insight. 2017 Jan 12;2(1):e89761. doi: 10.1172/jci.insight.89761.
2
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3.
3
HbS Binding to GP1bα Activates Platelets in Sickle Cell Disease.
PLoS One. 2016 Dec 9;11(12):e0167899. doi: 10.1371/journal.pone.0167899. eCollection 2016.
4
Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Ann Hematol. 2017 Jan;96(1):141-146. doi: 10.1007/s00277-016-2823-7. Epub 2016 Sep 30.
5
Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.
Br J Haematol. 2016 Dec;175(5):935-948. doi: 10.1111/bjh.14303. Epub 2016 Aug 23.
6
The association between blood group and the risk of vascular disease in Quebec blood donors.
Blood Transfus. 2016 Sep;14(5):455-9. doi: 10.2450/2016.0303-15. Epub 2016 Apr 28.
7
Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
Cochrane Database Syst Rev. 2015 Dec 18;2015(12):CD010155. doi: 10.1002/14651858.CD010155.pub3.
8
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.
9
Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice.
Blood. 2015 Nov 26;126(22):2511-7. doi: 10.1182/blood-2015-02-626234. Epub 2015 Aug 11.
10
Impact of sickle cell trait on the thrombotic risk associated with non-O blood groups in northern Nigeria.
Blood Transfus. 2015 Oct;13(4):639-43. doi: 10.2450/2015.0335-14. Epub 2015 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验